Navigation Links
Epstein-Barr virus may be associated with multiple sclerosis

Young adults with high levels of antibodies against the Epstein-Barr virus, the virus that most often causes mononucleosis, may be more likely to develop multiple sclerosis 15 to 20 years later, according to a study posted online today that will appear in the June 2006 print issue of Archives of Neurology, one of the JAMA/Archives journals.

Researchers have long suspected that external factors may influence the risk for multiple sclerosis (MS), a chronic autoimmune disease that affects the central nervous system, according to background information in the article. Some studies have suggested that the Epstein-Barr virus, which affects up to 96 percent of Americans by the time they reach age 35 to 40 years, may play a role.

Gerald N. DeLorenze, Ph.D., Kaiser Permanente Division of Research, Oakland, Calif., and colleagues examined the records of patients who joined a health plan between 1965 and 1974, when they were an average of 32.4 years old. The patients had undergone multiple examinations, answered questions about their health and behaviors and submitted blood samples, which were processed and stored at cold temperatures. Between 1995 and 1999, the researchers searched medical records maintained by the health plan and selected 42 individuals with MS who had blood samples in storage. Three people with blood samples but without MS were matched to each MS patient by age, sex and date of blood collection. The blood samples of all participants were then analyzed to determine the levels of antibodies against the Epstein-Barr virus. Measuring antibodies, proteins produced by the body to fight infection, is one way to determine exposure to or presence of a particular virus in a person's body.

The 36 women and six men who developed MS had their first symptoms at an average age of 45 years and an average of 15 years after their blood was collected. The average concentration of anti–Epstein-Barr virus antibodies was significantly higher among in dividuals who had developed MS than among those who hadn't--those with four times the level of antibodies were approximately twice as likely to develop MS. The elevated levels became evident between 15 and 20 years before patients first experienced the neurological symptoms of MS and remained higher afterward, the researchers reported.

Researchers don't yet understand how the Epstein-Barr virus causes the body to attack its own central nervous system, as it does in MS. "The mounting evidence that relates Epstein-Barr virus infection to other autoimmune diseases, particularly systemic lupus erythematosus (lupus), suggests that Epstein-Barr virus may have a broad role in predisposing to autoimmunity," or failure of the immune system to recognize the body's own tissues, the authors conclude. "A fine understanding of the mechanisms that connect Epstein-Barr virus infection to MS is important because it will provide the basis for the translation of this epidemiologic finding into new ways to treat and prevent MS."


'"/>

Source:JAMA and Archives Journals


Related biology news :

1. Epstein-Barr virus protein crucial to its role in blood cancers
2. U of T researchers map role of Epstein-Barr virus in cancer
3. Mechanism for Epstein-Barr virus proteins role in blood cancers discovered
4. Epstein-Barr virus might kick-start multiple sclerosis
5. Clue found to Epstein-Barr virus ability to form and sustain tumors
6. Association of herpesvirus with lung disorder questioned
7. Topical treatment shown to inhibit HIV and herpes simplex virus infection
8. Elusive HIV shape change revealed; Key clue to how virus infects cells
9. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
10. Live Recombinant Adenovirus Vaccine Technique Explored
11. Marburg virus disease in Angola - update
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2019)... ... February 20, 2019 , ... As ... medicine, the traditional line between engineering and medical science grows ever thinner. As ... the medical device industry is making medical practice easier for doctors, more effective ...
(Date:2/19/2019)... ... February 20, 2019 , ... ... see Dimensions rolled out across the organization. Dimensions provides in-depth data, visualizations, ... business, support strategic planning, and understand past and future funding activity. , ...
(Date:2/13/2019)... ... February 13, 2019 , ... Cambridge Innovation Institute (CII) is ... Ltd. which includes four annual Internet of Business (IoB) events in the ... , Phillips Kuhl, President, Cambridge Innovation Institute, says, "We are delighted to be ...
Breaking Biology News(10 mins):
(Date:2/14/2019)... N.J. (PRWEB) , ... February 14, 2019 , ... ... provider of helium based leak testing systems for the pharmaceutical, biotechnology and food ... the company moving forward. Brian Mulhall has been named Chief Executive ...
(Date:2/6/2019)... ... February 05, 2019 , ... Firmex ... executive management team to acquire Firmex, one of the fastest-growing and most widely-used ... Montreal-based private equity firm. Debt financing was provided by the Bank of Montreal. ...
(Date:2/2/2019)... ... , ... Dust off your Doc Martens, Virun Nutra-BioSciences is fusing punk rock ... Music and Tech Festival at the ESports Arena in Santa Ana on Wednesday afternoon, ... and dietary supplement industries, the Nuriv Music and Tech Festival is scheduled one day ...
(Date:2/2/2019)... ... 01, 2019 , ... Biomatlante, a world leader in synthetic ... Julien Dert, being effective on February 1st, 2019. , Graduated from ICN Business ... which more than 12 years in the Medical Device industry. Chief Financial Officer ...
Breaking Biology Technology: